K. Rajender Reddy
TitleCited byYear
Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection
MW Fried, ML Shiffman, KR Reddy, C Smith, G Marinos, FL Gonšales Jr, ...
New England Journal of Medicine 347 (13), 975-982, 2002
Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in variousá…
Antiplatelet Trialists' Collaboration
Bmj 308 (6921), 81-106, 1994
Boceprevir for untreated chronic HCV genotype 1 infection
F Poordad, J McCone Jr, BR Bacon, S Bruno, MP Manns, MS Sulkowski, ...
New England Journal of Medicine 364 (13), 1195-1206, 2011
Telaprevir for previously untreated chronic hepatitis C virus infection
IM Jacobson, JG McHutchison, G Dusheiko, AM Di Bisceglie, KR Reddy, ...
New England Journal of Medicine 364 (25), 2405-2416, 2011
Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection
A Regev, M Berho, LJ Jeffers, C Milikowski, EG Molina, NT Pyrsopoulos, ...
The American journal of gastroenterology 97 (10), 2614, 2002
Sofosbuvir for previously untreated chronic hepatitis C infection
E Lawitz, A Mangia, D Wyles, M Rodriguez-Torres, T Hassanein, ...
New England Journal of Medicine 368 (20), 1878-1887, 2013
Ledipasvir and sofosbuvir for previously treated HCV genotype 1 infection
N Afdhal, KR Reddy, DR Nelson, E Lawitz, SC Gordon, E Schiff, ...
New England Journal of Medicine 370 (16), 1483-1493, 2014
Ledipasvir and sofosbuvir for 8 or 12 weeks for chronic HCV without cirrhosis
KV Kowdley, SC Gordon, KR Reddy, L Rossaro, DE Bernstein, E Lawitz, ...
New England Journal of Medicine 370 (20), 1879-1888, 2014
Daclatasvir plus sofosbuvir for previously treated or untreated chronic HCV infection
MS Sulkowski, DF Gardiner, M Rodriguez-Torres, KR Reddy, ...
New England Journal of Medicine 370 (3), 211-221, 2014
Diagnosis and treatment of hepatocellular carcinoma
HB El-Serag, JA Marrero, L Rudolph, KR Reddy
Gastroenterology 134 (6), 1752-1763, 2008
ABT-450/r–ombitasvir and dasabuvir with or without ribavirin for HCV
P Ferenci, D Bernstein, J Lalezari, D Cohen, Y Luo, C Cooper, E Tam, ...
New England Journal of Medicine 370 (21), 1983-1992, 2014
Ledipasvir and sofosbuvir plus ribavirin for treatment of HCV infection in patients with advanced liver disease
M Charlton, GT Everson, SL Flamm, P Kumar, C Landis, RS Brown Jr, ...
Gastroenterology 149 (3), 649-659, 2015
Predicting sustained virological responses in chronic hepatitis C patients treated with peginterferon alfa-2a (40 KD)/ribavirin
P Ferenci, MW Fried, ML Shiffman, CI Smith, G Marinos, FL Gonšales Jr, ...
Journal of hepatology 43 (3), 425-433, 2005
Early identification of HCV genotype 1 patients responding to 24 weeks peginterferon α‐2a (40 kd)/ribavirin therapy
DM Jensen, TR Morgan, P Marcellin, PJ Pockros, KR Reddy, ...
Hepatology 43 (5), 954-960, 2006
Hepatitis-B-virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation
MM Bartholomew, RW Jansen, LJ Jeffers, KR Reddy, LC Johnson, ...
The Lancet 349 (9044), 20-22, 1997
Sofosbuvir and velpatasvir for HCV in patients with decompensated cirrhosis
MP Curry, JG O’Leary, N Bzowej, AJ Muir, KM Korenblat, JM Fenkel, ...
New England Journal of Medicine 373 (27), 2618-2628, 2015
α-fetoprotein, des-γ carboxyprothrombin, and lectin-bound α-fetoprotein in early hepatocellular carcinoma
JA Marrero, Z Feng, Y Wang, MH Nguyen, AS Befeler, LR Roberts, ...
Gastroenterology 137 (1), 110-118, 2009
Grazoprevir–elbasvir combination therapy for treatment-naive cirrhotic and noncirrhotic patients with chronic hepatitis C virus genotype 1, 4, or 6 infection: a randomized trial
S Zeuzem, R Ghalib, KR Reddy, PJ Pockros, ZB Ari, Y Zhao, DD Brown, ...
Annals of internal medicine 163 (1), 1-13, 2015
Efficacy and safety of pegylated (40-kd) interferon α-2a compared with interferon α-2a in noncirrhotic patients with chronic hepatitis C
KR Reddy, TL Wright, PJ Pockros, M Shiffman, G Everson, R Reindollar, ...
Hepatology 33 (2), 433-438, 2001
Hepatitis C virus genotypes in the United States: epidemiology, pathogenicity, and response to interferon therapy
NN Zein, J Rakela, EL Krawitt, KR Reddy, T Tominaga, DH Persing
Annals of internal medicine 125 (8), 634-639, 1996
The system can't perform the operation now. Try again later.
Articles 1–20